Philip Borel

On a need to know basis

There is no reason why private equity pay should be publicly disclosed, writes Private Equity International's Philip Borel.

A law with few friends(2)

Germany’s coalition government is working on a law for private equity. A number of drafts have been published, but no one seems satisfied, writes editorial director Philip Borel.

Permira doubles investment in charity fund

The buyout firm has committed €2m, fundraising expertise and executive support to Breakthrough, the social enterprise support group it co-founded in 2005.

German politician demands partial “locust” ban(3)

Peter Struck, head of the SPD faction in the German parliament, is calling for rules to limit private equity’s ability to take controlling stakes in some German companies.

German politician demands partial “locust” ban(2)

Peter Struck, head of the SPD faction in the German parliament, is calling for rules to limit private equity’s ability to take controlling stakes in some German companies.

CDC, Ronny John part company

Former Asian Development Bank executive Veronica John is leaving CDC, just six months after having joined the emerging markets private equity group earlier this year.

Moulton puts £12m into drugs clinic

UK private equity contrarian Jon Moulton has personally funded a purpose-built private drug addiction treatment centre in Kent.

BVCA says it won’t split

The battered UK trade organisation says it needs “sharper focus” but intends to remain a single organisation representing VCs, mid-market groups and big LBO funds under one roof.

Argos Soditic adds to buy-in tally

The European mid-market firm has backed a team of managers to acquire a fine chemicals company in France.

A law with few friends

Germany’s coalition government is working on a law for private equity. A number of drafts have been published, but no one seems satisfied, writes editorial director Philip Borel.